Most Anticipated Earnings: UNC-T, DAN-X and more Canadian Companies Reporting Earnings this Week (Nov 27-Dec 01)

It is a basket of common stocks including big U.S. companies. He is not sure about it but it is doing well for the caller. Income is the focus.

Making changes to be able to invest more in foreign stocks. Wait to see how they do.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research In Q4 – 2024, CGY reported a revenue growth rate of 3%, with revenues reaching $181M compared to last year’s $175.9M. Adjusted EBITDA margin improved in the quarter to 12.5% from 11.6% last year. Overall, these were acceptable numbers but not that strong, revenue growth…

Growing quickly, but not investing at this time. Good yield, but not major capital appreciation. However, ~5% dividend yield is safe. 

(A Top Pick Apr 18/24, Down 6.9%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with KEG.UN has triggered its stop at $13.50.  To remain disciplined, we recommend covering the position at this time.  This will result in a net investment loss of 3%, when combined with our previous recommendations.  

(A Top Pick Dec 14/23, Down 11%)Stockchase Research Editor: Michael O’Reilly Our PAST TOP PICK with SRV.UN has triggered its stop at $14.50.  To remain disciplined, we recommend covering the position at this time.  

They had a project where they had lent out some money to the big Urban Corp. real estate company, which defaulted on their loans. Fortunately, the loan was secured by some real estate. Terra Firma just announced getting full repayment of the principal plus interest for that property. Now it will be a function to…

Doesn't know the details of this but his comment is on how to play a sector when it gets bombed out like this. When the blue-chip (Potash (POT-T)) in the sector is really bombed out, your incentive to go into the juniors is a lot less. When potash comes back, the big player will have…

Sell CNR to buy BNS (down 3% today)? No. He'd stick with CNR. CNR is part of a true duopoly in Canada. Its infrastructure is extremely difficult to replicate. If there's a resurgence in transportation, this name will do well. Can outperform the overall market over the long term. It won't be a tremendous investment,…

Biden's renewable energy incentives will be a benefit. The backlog is in excess of $100M. They now have enough cash to build out opportunities. They are building rooftop installations in New York, Vermont and other places. Still holds a position.

Silver heavy, which is hard to get. A new addition to his portfolio. Likes management and properties. Excited about it. He's been moving from mid-tier to smaller streamers, which could get acquired, and this one could be one of those. It's small, so you'll have to be patient. You should also hold some of the…

Browse a daily summary of experts opinions on stocks and stock investment information.

Can't go wrong buying this one. One of his favourites in the space, along with BMO.

Sold on the money-laundering news. The fine wasn't the issue; it was the lid on acquisitions and cap on asset growth.

(A Top Pick Oct 20/23, Up 103%) It was undervalued, forgotten. Management has done a great job. Shares remain cheap as it pays a 4% dividend. Still likes it and would buy it now.

This is going to be the high-tech story in Canada. They developed a platform for real estate agents and have over 300,000 users now. The only problem with it was that it was not trading in the US, but it has now started trading there. Now a global operation. It’s illiquid.

Biggest bank weighting he has. Fits the bill for a long-term buy and hold, collect the dividend. Likes the expansion potential in the US. Some indigestion with BOTW, but kitchen-sinked the last quarter and stock surged. 

Can't go wrong buying this one. One of his favourites in the space, along with BMO.

They are providing almost a royalty payment to those wanting to financial auto dealership loans. They go out and borrow money and make royalty investment in those investing in a dealership. He is watching for them to make a third party investment outside of their dealer group. They pay a great dividend and have fantastic…

He's a dip-buyer of gold and a royalty name like has more correlation on the gold price than a miner like Barrick.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Latest results pretty good, with the highest silver assays reported to date. Strike length has increased and high-grade veins continue to be hit. IF (a big if) DV can connect the two zones then mineralization will increase materially. More infill drilling needs to be done, but the company…

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research The company claims to have the highest grade deposit of tungsten in the world, in Canada (Yukon and NWT), so in a safe jurisdiction. But as a developer it has no revenue, losses and negative cash flow. It does have $37M cash, however. Insiders own…

(Market Call Minute.) Deposit looks good, but it hasn't quite the size or the grade that it needs to move forward.

They are a developer, early stage, and looked to be on to a big discovery. Now it looks like a lower grade but economic mine. If you look at the valuation, it still looks like they are onto a high grade discovery. He would move on.

This has an igneous phosphate deposit, as opposed to the sedimentary type of deposit that comes from Morocco. They have a positive feasibility study and a very high CapX, and are working through the permitting cycle. What they need is one of the big agricultural companies to do a buyout and develop it. It’s not…

Great managers. Have a gold discovery in BC. It's high-risk, high-reward. They got nice financing before the current market rout. It's a good speculation, but not for long-term investors.

He likes the deposit and the CEO. They tried to finance them but Eagle beat them. You need to be concerned about the very recent revenue grab by the government of the Dominican Republic. It will be interesting to see how this works out. A great deposit and a great management team.

(A Top Pick Mar 05/19, Down 33%) A copper play in Serbia. It has three joint ventures including Newport. They still have a large land package that could lead to other projects. They also have assets in Bulgaria. He will continue to hold it.

Have received a notice of intent to make a takeover offer from one Australian zinc producer. Offer is at $3.90 a share. With take advantage of the market liquidity and usually money to advantage.

It has been a disappointing stock to him. They have had some hiccups, but likes their asset base. The problem is that synthetic diamonds are taking away from overall demand. They have not been operating as well as they should have been. He might prefer Lucara Diamond (LUC-T).

Has been a bit of a disaster. Mine in Texas is not going ahead, resource was not properly done. The reserves are not what they expected.

(Market Call Minute.) Colombia. A lot of chatter about it being a takeover.

Has a silver discovery in the Durango area of Mexico. It is a joint venture with Orex (REX-X) earning in. They are carried for 35% once Orex has earned in. A very interesting project. They drilled into an alteration zone and hit good mineralization which is fairly consistent and looks like it is averaging 2-250…

(Top Pick Aug 20/09, Down 40%) Still have an outstanding takeover offer. Investors are waiting to see if it is going to happen.

Potash in an area that is very close to deals that have been happening. On Junior potash plays in Saskatchewan, he is becoming worried about capital spending on account of foreign majors coming in. Concerned about the long-term prospects of this company.

We haven’t made many graphite discoveries in the world, mainly because there hasn’t been very much graphite required, relative to the supply. The graphite market is extremely technical, and not all graphite deposits are created equal. If you don’t understand the technology behind graphite and the various grades and qualities of graphite, be very, very…

A tricky one. Have a very small mine in Ireland that they are trying to put into production as well as a small jewellery division. There is no clear indication of what they are trying to be. Gold deposit is very small.

Has a massive nickel deposit in northern British Columbia. Low grade, but can be mined as an open pit. The jury is out on this one. Looks intriguing.

It seems the hole went right down the throat of what looked like a structural intersection. Also, it was reverse circulation, and the recovery wasn’t that good. An interesting deposit and in the part of Peru that is very dry, which is part of the issue of getting diamond drilling there.

Tempted to buy more. They may get a small royalty from a mine they found. They source really good simple projects to explore. There is no catalyst, but you are buying a good company for less than the cash in the bank.

Came out with really good results in Dominican Republic. Resource hopefully comes out by the end of the year.

Had owned this in the past. They operate in an interesting area and have a very interesting alloy, a combination of aluminum and others. They can make and cast extreme precision parts. The company expects to be profitable in the next couple of quarters. Have done a lot of things to improve their processes, and…

Has been a very frustrating stock in the Central African Republic. Reduced his holdings dramatically in the last year. Company announced they were going to have to defer some of their go ahead build of the mine because of some of the rebel forces and some of the issues.

Gave up on their play in British Columbia and has moved down to Peru. At this price and given the outstanding market cap the stock should do well with only a smidgen of success.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research FL has seen some executive turnover, including the CFO quitting. But it also in May released its pre-feasibility study on the PAK project, outlining life-of-minee cash flow of $8B on an initial ~$500M capital cost and net present value of $2.6B.  Drilling is ongoing. Insiders,…

(A Top Pick Nov 11/16. Down 39%.) Had a great initial discovery, but subsequent drilling results have not kept pace with initial drilling results. He likes the property and the people but sold his stock.

It's a 10 cent stock, when even the big companies aren't doing well. If you like it, sure go ahead. But there's nothing he can add.

(A Top Pick May 08/23, Up 36%) Recent discovery in Ghana is very large. Will share with G2, but in process of being sold. Will continue to hold. 

Doesn't own shares, but does not discourage ownership.Canadian assets worth looking at.Owns 3rd world nickel companies because they are cheaper valuations. 

(A Top Pick Oct 16/19, Down 24%) It is a prospect generator in Chile and Argentina. Their enterprise value is very low. They have a very high working capital position. Their permitting on drilling is slower than anticipated.

He bought it as a value play with sum of the parts worth more than it was trading at. They are trying to sell some of the parts. Thinks they will sell all the parts and distribute the cash. $4-$5 breakup value. It is taking longer than he thought to break it up.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research EPS of 1c missed estimates of 3.5c; revenue of $16.17M missed estimates of $16.46M. EBITDA of $4.75M beat estimates of 11%. Total sales rose 4.5%. Subscription sales rose 16.6%. SYZ bought back 85,700 shares. Canaccord raised its target by 50c to $12.50. Despite the 'miss'…

SCAN-X vs. PAT-X SCAN-X uses weapon detection technology that can scan up to 15 feet away. They have a market cap of $55 million. Compared with PAT-X, it is about one-quarter of the market value although the technology is very similar. He would prefer SCAN-X based on its value.

3D holograms. A year ago, it was 12-14 cents. Fallen off the radar, such a shame. Cutting edge. Product is pricey. Lots of pharma companies use it.

A play that could be triple / quadruple. Optical chips for next, next generation. 100 Gig data rates. High risk.

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Small bitcoin mining company. Increased its revenue well over the quarters. Good gross margins and recently profitable. It aims to hold the bitcoin that it mines on its balance sheet and as of December 2021, holds 169.3 bitcoin. Held up well considering the selloff in…

They provide digital services to retailers to allow quick changes to pricing and other tasks. They have a long history in this space and are trying to get into big-box stores. The company is small and new, so he's watching it. Once revenues ramp up, he'll enter.

Phenomenally good performance. Now at inflection point. Seeing more and bigger contracts both on surveillance and on batteries. Hopefully this is just getting started and it doesn't get bought out before the long runway of earnings growth and share price appreciation materializes.

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenue grew 57% YOY despite soft results in Q4 2021 relative to expectations. A strong second half of 2022 financial year is expected. Holds $8.5M in cash. In talks with Microsoft for a deal. Continues to trade at relatively low valuation. Results were not spectacular…

Emerging area of gaming, based on skill not luck. Fairly small company, so got hit by tax-loss selling and the small cap effect. Revenue should ramp up this year. Likes it here.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. MRS closed a small financing last week, but there has been no other news. Trading volume picked up a bit, but dollar value of trading remains quite low. Still, it is up 68% YTD with a January small cap bounce. Unlock Premium - Try 5i Free

Has pretty well fallen off the radar screen of most analysts. Sales are down 12%. Ranks in the bottom 20% of their database.

Bullish on the macro for industrial warehousing. Likes the focus in Toronto. Likes management. A show-me story, small. An opportunity. He's confident in their ability to grow. A bit expensive, so it's a bet on management and growth. On his radar for attractive entry points.

(A Top Pick Jan 14/21, Up 35.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with OGI has triggered its stop at $3.00. We recommend covering the balance of the position at this time. When combined with the previous recommendation to cover half the position, this results in a net investment gain over 46%.

This company used to be a junior miner and changed its business to developing a product called Zenguard which is a bio coating on masks. However masks are not used as much now. It is not profitable and there are other opportunities. The price target on the street is $2.33

There's been a lot of focus on cannabis in the US. Last November, Arizona legalized recreational weed and are starting to sell that. VEXT operates in many states, but particularly AZN. VEXT is still under the radar, but he expects them to grow rapidly, because they had a head start as a medical weed operator.…

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research IFX has seen revenues decline over the last 12 months, down -18.8% to $96.1M. The balance sheet is not as strong as earlier in the year with net debt rising to $7M and cash declining from prior periods to $3M. Cash from operations as well…

He holds the debentures, but not the stock. Management has executed as promised. Biodegradable packaging is gaining tons of traction. Industrial side has declined, now starting to recover. Massive cost-cutting. Pushing revenue up to a level that makes it an attractive takeover candidate.

A penny stock. Energy efficiency, energy management and storage solutions. A company with a technology that is going to help if we move to a decentralized grid where we want homes and businesses to be energy self-sufficient. Thinks it could do well but they are investing in a very specific type of technology. Can't tell…

Gathering steam, just at the cusp of taking off, and then Covid hit. One piece at a time, management is restructuring and building production towards being profitable. Las Vegas continues to be a tourist destination, plus favourable US legislation.

B Shares. In the process of liquidating their assets. If you own, he would be inclined to hold.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research For its fourth fiscal quarter, XTC matched EPS estimates of 20c. Revenue missed estimates of $160M coming in at $155.4M, declining 3% year-over-year. The company's outlook for next year calls for $750M in  revenue, $120M in EBITDA, and EPS of approximately $1.50. XTC cited, "Despite…

We need potash, and demand will spike. Reticent to chase a small name like this. Look to a large cap. He likes NTR, which is reasonably priced, all things considered.

They have massive expense lines with lots of debts, and their financials are opaque. This is not safe. He'd be very cautious. You must look at the fundamentals of any cannabis stock.

He likes the company still. Out of Latin America, they will probably take the lead. The sector is going through consolidation and it is a time to go shopping. He would look more at Charlotte's Web who has solid earnings. However, below $1.00 there is still value for it. Latin America doesn't have the same…

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research It is tough to forecast for a company that is pre-production. ETL recently stated that it may need to issue more shares and also that, "The company's ability to continue as a going concern is dependent upon its ability to fund its project and move…

(A Top Pick Jul 14/23, Up 129%) Small royalty generator through exploration skills. Producing royalty in Mexico going very well. Nevada silver royalty also producing high amounts of cash. Expecting more growth from the company. 

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research IF growth returns then CWL could do OK, but it has seen revenues decline for nearly the last two years. Margins also took a significant dip in 2023 and CWL generated a net loss. Looking back to years when CWL did see significant growth, it's…

A disappointment. Pandemic has been the nail in the coffin for movie theatres and DBO's motion systems. Simulation and industrial segments have been profitable. Treading water right now. Long road ahead. Wait and see before stepping in.

Thinks the newspaper business is going to have some fundamental issues going forward that are going to be fixable. None of the younger generation take newspapers.

Doesn't know this company. Loves the space. Names with a good name, like "green" move well. They produce organic foods, and people are looking to eat healthier. Fancy name. Fancy products.

They pick up vintage, expensive handbags they find in Asia then sell them here in kiosks. Interesting business, but has performed poorly. He didn't buy it.

Life sciences. Have an interesting regenerative technology. For example, they can take a hair follicle and extract certain cells, and then replicate them 1 million times and then re-inject them back in areas where they are needed. It is very, very rare to have a company this small with 2 products in phase 2 trials.…

He knows it very well, back to when they were private. They continue to build out. If they can allocate capital well, resulting in animated programs that are well-syndicated, then they should do well. If not, then this will be a lumpy stock. He needs to research them more.

This does mobile marketing for big brands, where you use your phone to run loyalty programs and purchase validations. Down 53% in the last year, because it got caught up in the downdraft in the TSX Venture. It would be higher today, except that their financing was the worst kept secret on Bay Street, which…

(A Top Pick Mar 19/24, Down 3.9%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with DOO has triggered its stop at $80.  To remain disciplined, we recommend covering the position at this time.  This will result in a net investment gain of 9%, when combined with our previous recommendations.  

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research RSI beat EPS estimates of 13c coming in at 14c. Revenue also beat estimates of $304.7M coming in at $333.03M increasing 10% year-over-year. Adjusted EBITDA was $141.6M up 28% year-over-year. The quarterly and full-year results look solid, with increasing sales driven by price increases and…

(A Top Pick Jan 23/24, Up 37%) Sells to hospitals, now expanding to pharmacies. Gold standard in US hospital network system. Recurring software revenues growing by over 30% a year, gross margins have expanded to over 70%. Guidance that EBITDA margins will exceed 10% next year. Trades at 3.5x revenues, huge discount to US peers.…

A market dollar in the past, but had financing and operational problems last year when revenues fell 50-60%. A lot of question marks here.

(A Top Pick April 23/13. Long Tag Oil (TAO-T) and Short Imperial Oil (IMO-T). Down 42.51%.) Did an equity issue last fall at about $4.40, which the Street didn’t like. This is a New Zealand oil/gas play and they have about 5 or 6 catalysts coming up in terms of major wells.

(Top May 21/14, Down 80.33%) He has trimmed some. They have no debt problem. It is totally out of favour. Don’t be concerned if they cut the dividend again. It will go up again when things improve.

One of the largest fleets of generation 3 and 4 deeper coil tubing. Two businesses: coil tubing and tools. Both are being run efficiently. Margin pressure in the sector. Great little story that will be a big beneficiary of LNG drilling. No debt. 5-year bull market target of $3. 2023 will be a pivotal year…

Pipeline in place right now, waiting for facilities. Big thing right now is a pending sales agreement. Management confirms this week that helium price has a chance to move up, and focus is on getting the sales agreement done. Once the agreement is in place, you can step in with a bigger position, because company…

The reserves and potential are there. They have lots of wells to drill over a five-year period. Slow and steady. They will need to finance it. Very cheap.

(Market Call Minute.) Good exploration play in New Zealand. If successful could derive a lot of upside but the market is made up for what they have already so we need to wait for the next batch of exploration results.

Involved in the UK North Sea. In the process of drilling a well with the Lundins that is very important. In about 1 month will start working with Husky (HSE-T) in the North West Territories. Between the winters of 2008 and 2009, you will have a good shot if they have any kind of drilling…

He was stopped out over a year ago. They are an emerging compunder, but didn't like their weak disclosure. He stopped looking at this. Watch your allocation size for stocks like this, because they can soar or plunge.

Launched a data-capture platform for clinical trials today One reason they bought BioPharma was to digitize it, so the announcement is no surprise. THNK digitizes data and enables the connection between healthcare, government and patients through their software. They digitize clinical data, like trial data. This is one of his two e-health holdings. Its valuation…

(A Top Pick May 11/21, Down 86%) Still likes the company, however doesn't own shares (even though recommends it). Thought there would be more growth in stock price.

Produces a very small x-ray device that requires no maintenance. Have not been able to increase sales. No information or earnings estimates from analysts.

They've done financing, rising from 80 cents to $4 then back to $1. A round trip. They're opening a big cannabis supercentre in Vegas that'll probably do well, but this stock got expensive. And cannabis is still speculative. He's waiting-and-seeing.

It is now focusing on Mobile EV charging. It had previously sold Covid test kits. Has a $32 million market cap. It is a difficult business to make money in, is not profitable, and there are better options. (Analysts’ price target is $0.12)

In Canada, this smallcap (C$210 million) biotech in Halifax submitted its antibody test to the FDA. Since April 22, MedMira has soared from 6 cents/share to over 30. There's scant coverage or even stock metrics to report. Also MedMira is one of many companies to submit such tests to the FDA, but it's worth keeping…

They take a large nuclear magnetic resonance machine and shrink it down to a desk top size. They now have a high def version. Theirs is better than their nearest competitor. It won't be profitable until 2021.

Did very well during the pandemic, a market darling then. But their acquisitions didn't make sense to him and they have caught up with them with poor integration. The hype is over and shares have plunged since 2020.

Brazilian order? He owns warrants and his wife works as a consultant for them. They have orders for 500 units for a melanoma testing product. The delivery is subject to approval by authorities in Brazil. This could lead to hardware sales by June and revenues that begin to show up in Q4. The company thinks…

They make life easier for large diagnostic test companies. It automates the testing process. They did a final financing. They've been working on this technology for 5 years.

A very well run company with a really interesting variety of nickel exposure in Norway and 1st rate exploration projects.